The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index; none of the 107 sources its claims cite is checked for support yet.
Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Open accessAbstract
Senescent cells are generally characterized by permanent cell cycle arrest, metabolic alteration and activation, and apoptotic resistance in multiple organs due to various stressors. Excessive accumulation of senescent cells in numerous tissues leads to multiple chronic diseases, tissue dysfunction, age-related diseases and organ ageing. Immune cells can remove senescent cells. Immunaging or impaired innate and adaptive immune responses by senescent cells result in persistent accumulation of various senescent cells. Although senolytics—drugs that selectively remove senescent cells by inducing their apoptosis—are recent hot topics and are making significant research progress, senescence immunotherapies using immune cell-mediated clearance of senescent cells are emerging and promising strategies to fight ageing and multiple chronic diseases. This short review provides an overview of the research progress to date concerning senescent cell-caused chronic diseases and tissue ageing, as well as the regulation of senescence by small-molecule drugs in clinical trials and different roles and regulation of immune cells in the elimination of senescent cells. Mounting evidence indicates that immunotherapy targeting senescent cells combats ageing and chronic diseases and subsequently extends the healthy lifespan.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that excessive senescent cells drive ageing and chronic diseases, and that immune-mediated clearance by macrophages, NK cells, cytotoxic T cells, and dendritic cells is a promising anti-ageing strategy. It surveys senolytics and small-molecule drugs in preclinical and clinical development and outlines immune mechanisms and future directions for senescence immunotherapy.
Key findings
- Senescent cells accumulate with age and causally contribute to tissue dysfunction, organ ageing, and chronic diseases including cardiovascular disease, cancer, neurodegenerative diseases, and osteoarthritis; immune cells can remove them, but immunosenescence and impaired innate/adaptive responses promote persistent accumulation.
- Senescence immunotherapy is emerging as an alternative or complement to senolytics: macrophages, NK cells, cytotoxic T cells, and dendritic cells recognize distinct senescent-cell ligands, such as NKG2D ligands MICA/ULBP2 on senescent cells, while HLA-E–NKG2A interaction inhibits NK/CD8+ T-cell clearance.
- Small molecules and senolytics show reported benefits: dasatinib plus quercetin (D + Q) eliminates senescent cells in human adipose tissue and skin and improves physical function in idiopathic pulmonary fibrosis; nicotinamide mononucleotide (NMN) was safe after single oral administration in healthy men; topical rapamycin reduced p16 expression in human skin; metformin has entered multiple clinical trials including MILES and TAME.
- In human immune ageing, supercentenarians older than 110 years had increased CD4+ cytotoxic T lymphocytes (~25.3% of total T cells) versus only 2.8% in young controls (~50–80 year olds), with a dramatic reduction in B-cell number compared with controls.
Methods
- Narrative review synthesizing preclinical animal models, human samples, mechanistic studies, and clinical trials; no systematic review or meta-analysis is described.
- Main analysis is qualitative and organized around senescent-cell features, senescent-cell-driven diseases and tissue ageing, small-molecule regulation of senescence, and immune cell types involved in senescent-cell clearance.
- Clinical trial examples cited include NCT03151239 for NMN safety, NCT03103893 for topical rapamycin, the Metformin in Longevity Study (MILES), NCT02570672 for metformin and frailty, NCT02915198 for metformin in pre-diabetes and atherosclerotic cardiovascular disease, and the proposed TAME trial.
Limitations
- The paper states that the precise mechanism underlying senescent cell accumulation within tissues is still debatable, and it is unknown whether this is due to senescent cell increase exceeding immune clearance or immune cell dysfunction.
- The paper states that whether macrophages remove senescent cells in aged or diseased systems remains to be elucidated, and it remains extremely unknown whether and how dendritic cells eliminate apoptotic or senescent cells to prevent chronic diseases including atherosclerosis.
- The paper states that senescence immunotherapy is not cost-free and does have side effects, and future investigations are needed for personal ageing biomarkers, unique senescent-cell antigens or ligands, and inclusion of both genders; evident from the text, many proposed immunotherapies such as CAR-T/CAR-NK targeting senescent cells and anti-NKG2A strategies are still speculative or not yet established in clinical senescence settings.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 107 cited sources checked · 0 supported · 0 flagged
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although senolytics—drugs that selectively remove senescent cells by inducing their apoptosis—are recent hot topics and are making significant research progress, senescence immunotherapies using immune cell-mediated clearance of senescent cells are emerging and promising strategies to fight ageing and multiple chronic diseases.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Cellular senescence plays beneficial critical roles in numerous biological processes [5], such as tumor suppression [6,7], embryonic tissue remodeling [8] and wound healing after injury [9].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 1. Introduction
What the sources say
- Not checked yetcites [5] Burton, 2014, Physiological and pathological consequences of cellular senescence, Cell Mol. Life Sci. source
- Not checked yetcites [6] Lin, 2010, Skp2 targeting suppresses tumorigenesis by arf-p53-independent cellular senescence, Nature source
- Not checked yetcites [7] Braig, 2005, Oncogene-induced senescence as an initial barrier in lymphoma development, Nature source
- Not checked yetcites [8] Canamero, 2013, Programmed cell senescence during mammalian embryonic development, Cell source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Immune cells can remove senescent cells.”
- Also stated in: § 3. Immunosurveillance of Senescent Cells · plain
“Generally, senescent cells can be removed by apoptosis and the immune system [121,122].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > Abstract
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § 3. Immunosurveillance of Senescent Cells · plain
In the paper
“Immunaging or impaired innate and adaptive immune responses by senescent cells result in persistent accumulation of various senescent cells.”
- Also stated in: § 3. Immunosurveillance of Senescent Cells · plain
“Senescent cells recruit and make immune cells senescent and dysfunctional via SASP, leading to persistent and excessive accumulation of senescent cells [122].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > Abstract
What the sources say
- Not checked yetcites [122] Prata, 2018, Senescent cell clearance by the immune system: Emerging therapeutic opportunities, Semin. Immunol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § 3. Immunosurveillance of Senescent Cells · plain
In the paper
“Senescent cells in patients with idiopathic pulmonary fibrosis (IPF) drive physical dysfunction [45].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [45] Justice, 2019, Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study, EBioMedicine source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Zhang et al. employed a senolytic cocktail of dasatinib plus quercetin (D + Q) to validate that senescent OLIG2- and NG2-expressing oligodendrocyte progenitor cells (OPCs) contribute to cognitive impairment in an AD mouse model [56].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [56] Zhang, 2019, Senolytic therapy alleviates aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an alzheimer’s disease model, Nat. Neurosci. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Senescence of the central nervous system (CNS) drives many neurodegenerative diseases [55], including Alzheimer’s disease (AD), Parkinson’s disease (PD) and other types of dementia (Table 1).”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [55] Kritsilis, M., V Rizou, R., Koutsoudaki, P.N., Evangelou, K., Gorgoulis, V.G., and Papadopoulos, D. (2018). Ageing, cellular senescence and neurodegenerative disease. Int. J. Mol. Sci., 19. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Cellular senescence traditionally impairs stem-cell function (also termed as stemness) [58].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [58] Golomb, 2015, Age-associated inflammation connects ras-induced senescence to stem cell dysfunction and epidermal malignancy, Cell Death Differ. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Mounting evidence from human samples and preclinical animal models shows that the excessive presence of senescent cells is a contributing cause of ageing, which is featured by a functional decline in multiple physiological systems [39,40].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, the senescence of specific cancer cells develops cancer stemness.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [2] Milanovic, 2018, Senescence-associated reprogramming promotes cancer stemness, Nature source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Excessive senescent cells have been demonstrated to play a causal role in driving ageing [26] and chronic diseases [18] using genetic and pharmacologic approaches.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Another crucial feature of senescent cells is apoptotic resistance, which is, in part, attributable to the transcriptional and cap-independent translational elevation of anti-apoptotic B-cell lymphoma 2 (BCL-2) family proteins (BCL-2, BCL-XL and BCL-W) [36].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.1. Features of Cellular Senescence
What the sources say
- Not checked yetcites [36] Yosef, 2016, Directed elimination of senescent cells by inhibition of bcl-w and bcl-xl, Nat. Commun. source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These results suggest that senescent glial cells drive tau-dependent disease.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Additionally, macrophage senescence instigates features of plaque instability, such as elastic fiber defects and fibrous cap thinning in the brachiocephalic artery and descending aorta [47].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [47] Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Accumulation of senescent endothelial cells leads to cardiovascular thrombotic complications, including arterial (acute myocardial infarction, stroke) and venous (deep vein thrombosis, pulmonary embolism) thrombotic events [52].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [52] Bochenek, 2016, Endothelial cell senescence and thrombosis: Ageing clots, Thromb. Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Senescence of vascular smooth muscle cells (VSMCs) generally drives the vulnerability of atherosclerotic plaques resulting in myocardial infarction and stroke [54].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [54] Wang, 2015, Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability, Circulation source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Additionally, senescent astrocytes mediate dopaminergic neurodegeneration related to PD [57].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [57] Chinta, 2018, Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to parkinson’s disease, Cell Rep. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“It was reported that premature endothelium senescence reversibly triggers vascular ageing and the age-associated decrease in exercise endurance in old mice [42].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [42] Das, 2018, Impairment of an endothelial nad(+)-h2s signaling network is a reversible cause of vascular aging, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Senescent cardiovascular cells specifically contributes to chronic CVD, including atherosclerosis [47], abdominal aortic aneurysm (AAA) [48], thoracic aortic aneurysm (TAA) [49], artery stiffness [50] and heart failure [51].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [47] Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science source
- Not checked yetcites [48] Chen, 2016, Age-associated sirtuin 1 reduction in vascular smooth muscle links vascular senescence and inflammation to abdominal aortic aneurysm, Circ. Res. source
- Not checked yetcites [49] Watson, 2017, Nicotinamide phosphoribosyltransferase in smooth muscle cells maintains genome integrity, resists aortic medial degeneration, and is suppressed in human thoracic aortic aneurysm disease, Circ. Res. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Different senescent cells with unique features have distinct functions in tissue ageing and various chronic diseases.”
- Also stated in: § 2.1. Features of Cellular Senescence · hedged
“It is noteworthy that different senescent cells have unique features, which may lead to distinct types of ageing patterns in different individuals [38].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases
What the sources say
- Not checked yetcites [38] Ahadi, 2020, Personal aging markers and ageotypes revealed by deep longitudinal profiling, Nat. Med. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Also stated in: § 2.1. Features of Cellular Senescence · hedged
In the paper
“T-cell senescence is profoundly associated with physical frailty [46].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [46] Ng, 2015, Markers of t-cell senescence and physical frailty: Insights from singapore longitudinal ageing studies, NPJ Aging Mechan. Dis. source
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Macrophage transcription factors Kruppel-like factors 2 (KLF2) and 4 (KLF4) are crucial controllers inducing gene expression necessary to silently eradicate apoptotic cells [138].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [138] Roberts, 2017, Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells, Immunity source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“interferon regulatory factor 5 (IRF5) transcription factor enhances vulnerable plaque formation in hyperlipidemic apolipoprotein E-deficient (ApoE−/−) mice through the induction of pro-inflammatory CD11c+ macrophages within atherosclerotic lesions and increasing the expansion of the necrotic core by inhibiting macrophage efferocytosis [142].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [142] Seneviratne, 2017, Interferon regulatory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis, Circulation source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“activated Treg cells secrete IL-13 to stimulate IL-10 production in macrophages via binding to the IL-13 receptor.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [139] Proto, 2018, Regulatory t cells promote macrophage efferocytosis during inflammation resolution, Immunity source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Senescence immunotherapy strategy is also a promising alternative to senolytics to remove senescent cells in the prevention and cure of ageing and chronic diseases (Table 2).”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: Findings from animal models and preclinical studies of senescent cell clearance will translate to human ageing and chronic diseases.
- Rests on an assumption: Targeting or clearing senescent cells can be done safely without eliminating beneficial functions of acute or transient senescence.
None of the sources cited for this claim have been checked yet.
In the paper
“Although senescent cells can be induced to undergo apoptosis by senolytics and further removed by macrophages, macrophages also directly engulf senescent cells in cancer (Figure 1).”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“cyclin-dependent kinase inhibitor 2B (CDKN2B)-deficient apoptotic cells show decreased expression of calreticulin [149]”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [149] Kojima, 2014, Cyclin-dependent kinase inhibitor 2b regulates efferocytosis and atherosclerosis, J. Clin. Investig. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because apoptosis evasion features most senescent cells, the immune system, including adaptive and innate immune cells, plays a critical role in the eradication of senescent cells at a young stage or under physiological conditions.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Generally, senescent cells can be removed by apoptosis and the immune system [121,122].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“p53 reconstitution induces liver tumor cell senescence with increased p16 and SA β-gal activity but not apoptosis, in mice in vivo.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [145] Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“apoptotic or senescent cells have increased expression of cell-surface protein CD47, one of the “don’t eat me” signals, which impairs efferocytosis via binding to the inhibitory receptor signal regulatory protein alpha (SIRPα) on the macrophage.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [148] Kojima, 2016, Cd47-blocking antibodies restore phagocytosis and prevent atherosclerosis, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“For example, senescence-activated hepatic stellate cells upregulate cell-surface MICA and ULBP2, ligands of activating receptor NKG2D on NK cells [20].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [20] Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“The elevated IL-10 signaling upregulates macrophage STAT3-mediated VAV1 (a guanine nucleotide exchange factor), which activates GTPase Rac1 to enhance apoptotic cell engulfment by macrophages [139].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [139] Proto, 2018, Regulatory t cells promote macrophage efferocytosis during inflammation resolution, Immunity source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Specific populations of innate immune effector macrophages take up apoptotic cells in particular tissues, known as efferocytosis, which prevents apoptotic cells from being necrotic or pro-inflammatory [138].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [138] Roberts, 2017, Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells, Immunity source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“which is a principal ligand required for engulfment activation via binding and activating LDL-receptor-related protein (LRP) on macrophages [150].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [150] Gardai, 2005, Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of lrp on the phagocyte, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“It is noteworthy that the sustainable clearance of multiple apoptotic cells by macrophages requires dynamin-related protein 1 (DRP1)-mediated macrophage mitochondrial fission, allowing calcium release from mitochondria into the cytoplasm, triggered by the initial uptake of apoptotic cells [147].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [147] Wang, 2017, Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages, Cell source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Mounting evidence demonstrates that immune surveillance of senescent cells is executed by different immune cells such as macrophages, natural killer (NK) cells and cytotoxic T cells in cancer [5,130] and chronic liver cirrhosis [20].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [5] Burton, 2014, Physiological and pathological consequences of cellular senescence, Cell Mol. Life Sci. source
- Not checked yetcites [130] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
- Not checked yetcites [20] Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Different immune cells have a distinct capability to identify and eliminate the unique senescent cells.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Yang et al. reported that the C-type lectin receptor LSECtin (Clec4g) on colon macrophages is required for macrophage engulfment and clearance of apoptotic cells, contributing to intestinal repair in dextran sulphate sodium-induced colitis [146].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [146] Yang, 2018, C-type lectin receptor lsectin-mediated apoptotic cell clearance by macrophages directs intestinal repair in experimental colitis, Proc. Natl. Acad. Sci. USA source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“This selectivity is due to selective upregulation of NKG2D ligands MICA and ULBP2 in senescent IMR-90 cells but not growing or quiescent cells [151].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [151] Sagiv, 2016, Nkg2d ligands mediate immunosurveillance of senescent cells, Aging source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“HLA-E expression is also increased in the senescent fibroblasts of human skin during ageing.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [124] Pereira, 2019, Senescent cells evade immune clearance via hla-e-mediated nk and cd8(+) t cell inhibition, Nat. Commun. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Moreover, supplementation with exogenous calreticulin restores the clearance of CDKN2B-deficient apoptotic cells by macrophages [149].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [149] Kojima, 2014, Cyclin-dependent kinase inhibitor 2b regulates efferocytosis and atherosclerosis, J. Clin. Investig. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“CD4+ cytotoxic T cells can directly kill senescent tumor cells by recognizing MHC II molecules, which are usually absent in healthy cells but present in a subset of tumor or senescent cells [130].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [130] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“NKG2D receptor deletion instigates the accumulation of senescent stellate cells, resulting in increased liver fibrosis in mice in vivo [151].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [151] Sagiv, 2016, Nkg2d ligands mediate immunosurveillance of senescent cells, Aging source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“CD11b+ DCs with dysfunctional autophagy due to Atg16l1 deficiency expand aortic CD4+ Treg cells and inhibit atherogenesis in Ldlr−/− mice [162].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [162] Clement, 2019, Impaired autophagy in cd11b(+) dendritic cells expands cd4(+) regulatory t cells and limits atherosclerosis in mice, Circ. Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“senescent cells generate specific cell-surface antigen, such as band 3 [158]”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [158] Kay, 1993, Generation of senescent cell antigen on old cells initiates igg binding to a neoantigen, Cell Mol. Biol.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“CD24+ DCs generally exert their removal function via T-cell regulation.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [161] Cummings, 2016, Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs, Nature source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“high expression of fibroblast activation protein (FAP) in active cardiac fibroblasts but not cardiomyocytes, drives abundant cardiac fibrosis and consequent myocardial disease [134].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [134] Aghajanian, 2019, Targeting cardiac fibrosis with engineered t cells, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Reinstructing cytotoxic T cells to identify specific antigens on cancer cells using either a modified T-cell receptor or a chimeric antigen receptor (CAR) has been successfully used for specific cancer therapies [156].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [156] June, 2018, Car t cell immunotherapy for human cancer, Science source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“CD103+ DCs selectively carry apoptotic intestinal epithelial cells to mesenteric lymph nodes, which function as critical determinants to induce tolerogenic CD4+ regulatory T-cell differentiation in mice [161].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [161] Cummings, 2016, Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs, Nature source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Indoleamine 2,3-dioxygenase 1 (IDO1)-expressing and chemokine (C-C motif) receptor 9 (CCR9)-positive plasmacytoid dendritic cells (pDCs) in the aorta locally induce aortic Treg cells, which produce IL-10 and subsequently prevent atherogenesis in mice [163].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [163] Yun, 2016, Indoleamine 2,3-dioxygenase-expressing aortic plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory t cells, Cell Metab. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Dendritic cells (DCs), a professional phagocytic cell type, can also identify and eradicate apoptotic cells [160].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [160] Albert, 1998, Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and cd36, and cross-present antigens to cytotoxic t lymphocytes, J. Exp. Med. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“CD8+ cytotoxic T cells directly eradicate target cells using cytotoxic molecules via recognizing MHC I molecules within nearly all cells [127].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [127] Hashimoto, 2019, Single-cell transcriptomics reveals expansion of cytotoxic cd4 t cells in supercentenarians, Proc. Natl. Acad. Sci. USA source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“These ligands enhance NK cell susceptibility [137].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [137] Soriani, 2009, Atm-atr-dependent up-regulation of dnam-1 and nkg2d ligands on multiple myeloma cells by therapeutic agents results in enhanced nk-cell susceptibility and is associated with a senescent phenotype, Blood source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because senescent cells are also beneficial in the short term, the homeostasis of senescent cells is critical for healthy ageing.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 4. Conclusions and Future Perspectives
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: Senescent cells are beneficial in the short term.
In the paper
“Chemotherapeutic drugs, including doxorubicin, melphalan and bortezomib, upregulate both the DNAX accessory molecule-1 (DNAM-1; CD226) ligand PVR (poliovirus receptor; CD155) and NKG2D ligands (MICA and MICB) on multiple myeloma cells presenting a senescent phenotype.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [137] Soriani, 2009, Atm-atr-dependent up-regulation of dnam-1 and nkg2d ligands on multiple myeloma cells by therapeutic agents results in enhanced nk-cell susceptibility and is associated with a senescent phenotype, Blood source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“the YT human NK cell line preferentially destroys senescent IMR-90 fibroblasts [20].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [20] Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“HLA-E then inhibits immune cytotoxicity targeting senescent cells by interacting with the inhibitory receptor NKG2A expressed on NK cells [124].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [124] Pereira, 2019, Senescent cells evade immune clearance via hla-e-mediated nk and cd8(+) t cell inhibition, Nat. Commun. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“NK cells are involved in the elimination of senescent cells through interaction between the activating NKG2D receptor and its ligands expressed on senescent cells.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [20] Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“perforin- and granzyme-containing granule exocytosis but not death-receptor-mediated apoptosis, is required for NK cell-mediated killing of senescent cells [40].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [40] Ovadya, 2018, Impaired immune surveillance accelerates accumulation of senescent cells and aging, Nat. Commun. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Pereira et al. recently reported that senescent human primary dermal fibroblasts and endothelial cells express higher levels of the atypical major histocompatibility complex (MHC) Ib molecule HLA-E via the p38 signaling pathway than non-senescent cells.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [124] Pereira, 2019, Senescent cells evade immune clearance via hla-e-mediated nk and cd8(+) t cell inhibition, Nat. Commun. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“c-Jun overexpression protects CAR-T cells from dysfunction by inducing T-cell exhaustion resistance [157].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [157] Lynn, 2019, C-jun overexpression in car t cells induces exhaustion resistance, Nature source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 25
- Probably not a substantial claim. 5
None of the sources cited for this claim have been checked yet.
In the paper
“However, excessive accumulation of senescent cells causally shortens the healthy lifespan [11] and drives organ ageing [12], age-related organ deterioration/disorders [13,14], tissue dysfunction and chronic diseases, including cardiovascular diseases (CVDs) [15,16], cancer [2], neurodegenerative diseases [17,18] and osteoarthritis [19].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 1. Introduction
What the sources say
- Not checked yetcites [11] Baker, 2016, Naturally occurring p16(ink4a)-positive cells shorten healthy lifespan, Nature source
- Not checked yetcites [12] Childs, 2015, Cellular senescence in aging and age-related disease: From mechanisms to therapy, Nat. Med. source
- Not checked yetcites [13] Baker, 2011, Clearance of p16ink4a-positive senescent cells delays ageing-associated disorders, Nature source
- Not checked yetcites [14] Childs, 2017, Senescent cells: An emerging target for diseases of ageing, Nat. Rev. Drug Discov. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mounting evidence indicates that immunotherapy targeting senescent cells combats ageing and chronic diseases and subsequently extends the healthy lifespan.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
- Rests on an assumption: Findings from animal models and preclinical studies of senescent cell clearance will translate to human ageing and chronic diseases.
- Rests on an assumption: Targeting or clearing senescent cells can be done safely without eliminating beneficial functions of acute or transient senescence.
None of the sources cited for this claim have been checked yet.
In the paper
“Cellular senescence is a cell state in which the cell-cycle is generally irreversibly stopped [1], with cell-cycle reentry being a plausible scenario under specific circumstances, particularly in tumor cells [2].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 1. Introduction
What the sources say
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“p16Ink4a (encoded by the INK4a/ARF locus, also known as CDKN2a, hereafter referred to as p16)-induced senescence of mouse and human pancreatic beta cells also promotes insulin secretion [10].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 1. Introduction
What the sources say
- Not checked yetcites [10] Helman, 2016, P16(ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion, Nat. Med. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Senescent cells are generally characterized by permanent cell cycle arrest, metabolic alteration and activation, and apoptotic resistance in multiple organs due to various stressors.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > Abstract
What the sources say
- Not checked yetcites [1] Gorgoulis, 2019, Cellular senescence: Defining a path forward, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Excessive accumulation of senescent cells in numerous tissues leads to multiple chronic diseases, tissue dysfunction, age-related diseases and organ ageing.”
- Also stated in: § 1. Introduction · plain
“However, excessive accumulation of senescent cells causally shortens the healthy lifespan [11] and drives organ ageing [12], age-related organ deterioration/disorders [13,14], tissue dysfunction and chronic diseases, including cardiovascular diseases (CVDs) [15,16], cancer [2], neurodegenerative diseases [17,18] and osteoarthritis [19].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > Abstract
What the sources say
- Not checked yetcites [11] Baker, 2016, Naturally occurring p16(ink4a)-positive cells shorten healthy lifespan, Nature source
- Not checked yetcites [12] Childs, 2015, Cellular senescence in aging and age-related disease: From mechanisms to therapy, Nat. Med. source
- Not checked yetcites [13] Baker, 2011, Clearance of p16ink4a-positive senescent cells delays ageing-associated disorders, Nature source
- Not checked yetcites [14] Childs, 2017, Senescent cells: An emerging target for diseases of ageing, Nat. Rev. Drug Discov. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § 1. Introduction · plain
None of the sources cited for this claim have been checked yet.
In the paper
“There are two major types of cellular senescence: stress-induced premature cellular senescence [3] and replicative senescence due to a repeated cell cycle, which is usually mediated by telomere shortening [4].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 1. Introduction
What the sources say
- Not checked yetcites [3] Liu, 2015, Impact of er stress-regulated atf4/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy, Am. J. Physiol. Cell Physiol. source
- Not checked yetcites [4] Mao, 2012, Replicatively senescent cells are arrested in g1 and g2 phases, Aging source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Recently, cyclic guanosine monophosphate-adenosine monophosphate (GMP-AMP) synthase (cGAS) was shown to recognize cytosolic DNA in senescent cells to produce cGAMP, which triggers the generation of SASP factors via stimulator of interferon genes (STING) and promotes paracrine senescence [35].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.1. Features of Cellular Senescence
What the sources say
- Not checked yetcites [35] Gluck, 2017, Innate immune sensing of cytosolic chromatin fragments through cgas promotes senescence, Nat. Cell Biol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The first-in-human open-label pilot study indicates that D + Q directly eliminates senescent cells in human adipose tissue and skin [120] and significantly improves the physical function of participants with idiopathic pulmonary fibrosis [45].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.3. Regulation of Cellular Senescence and Consequent Tissue Ageing and Disorders
What the sources say
- Not checked yetcites [120] Hickson, 2019, Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease, EBioMedicine source
- Not checked yetcites [45] Justice, 2019, Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study, EBioMedicine source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Senescent cells generally demonstrate an enlarged and flattened cell morphology [27] and expanded nucleoli [28,29], enhanced senescence-associated beta-galactosidase (SA-β-gal) activity [30], telomere shortening, elevation of the cyclin-dependent kinase inhibitor p16 [11,31] or p21 [32], macromolecular damage and metabolism dysfunction [1].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.1. Features of Cellular Senescence
What the sources say
- Not checked yetcites [27] Mammoto, 2019, Effects of age-dependent changes in cell size on endothelial cell proliferation and senescence through yap1, Aging source
- Not checked yetcites [28] Buchwalter, 2017, Nucleolar expansion and elevated protein translation in premature aging, Nat. Commun. source
- Not checked yetcites [29] Tiku, 2017, Small nucleoli are a cellular hallmark of longevity, Nat. Commun. source
- Not checked yetcites [30] Matthews, 2006, Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress, Circ. Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Lipofuscin is an emerging and more sensitive biomarker than SA-β-gal activity for cellular senescence in vitro and in vivo.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.1. Features of Cellular Senescence
What the sources say
- Not checked yetcites [37] Evangelou, 2017, Robust, universal biomarker assay to detect senescent cells in biological specimens, Aging Cell. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Bussian et al. reported that clearance of p16+ senescent astrocytes and microglia using INKATTAC transgene restrains gliosis, super-phosphorylation of both soluble and insoluble tau resulting in neurofibrillary tangle deposition and degeneration of cortical and hippocampal neurons, thus restoring cognitive function.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 2. Cellular Senescence Causally Contributes to Ageing and Chronic Diseases > 2.2. Senescent Cells Drive Ageing and Various Chronic Diseases
What the sources say
- Not checked yetcites [18] Bussian, 2018, Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cellular senescence accumulation usually arises from increased stresses-induced cellular senescence and reduction of senescent cell removal due to apoptosis evasion and/or immune system dysfunction.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 1. Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“DRP1-deficient macrophages present impaired efferocytosis in vivo and subsequently increased plaque necrosis in advanced atherosclerotic lesions of Western diet-fed LDLR knockout mice [147].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [147] Wang, 2017, Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Both macrophage and apoptotic or senescent cells control macrophage efferocytosis ability.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“These senescent tumor cells recruit innate immune cells, such as macrophages, leading to the eradication of senescent tumor cells and subsequent tumor regression [145].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [145] Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Antibodies blocking CD47 reactivate efferocytosis of diseased vascular tissue without altering cellular apoptosis, as well as alleviate atherosclerosis in both the aortic sinus and en face of the aorta in multiple mouse models [148].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [148] Kojima, 2016, Cd47-blocking antibodies restore phagocytosis and prevent atherosclerosis, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Senescent cells recruit and make immune cells senescent and dysfunctional via SASP, leading to persistent and excessive accumulation of senescent cells [122].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells
What the sources say
- Not checked yetcites [122] Prata, 2018, Senescent cell clearance by the immune system: Emerging therapeutic opportunities, Semin. Immunol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“F4/80+ macrophages are also key players in the removal of senescent uterine cells after parturition to keep postpartum uterine functionality in wild-type mice and maintain the success rate of a second pregnancy in a preterm birth mouse model [135].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [135] Egashira, 2017, F4/80+ macrophages contribute to clearance of senescent cells in the mouse postpartum uterus, Endocrinology source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Kang et al. demonstrated that CD4+ T cells require monocytes/macrophages but not NK cells, to remove pre-malignant senescent hepatocytes, subsequently blocking liver tumor development [130].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [130] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The impaired ability of macrophage efferocytosis would enhance atherogenesis [139,140,141] and atherosclerotic plaque instability [142,143,144].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [139] Proto, 2018, Regulatory t cells promote macrophage efferocytosis during inflammation resolution, Immunity source
- Not checked yetcites [140] Schrijvers, 2005, Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis, Arterioscler. Thromb. Vasc. Biol. source
- Not checked yetcites [141] Kojima, 2017, The role of efferocytosis in atherosclerosis, Circulation source
- Not checked yetcites [142] Seneviratne, 2017, Interferon regulatory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis, Circulation source
- Not checked yetcites [143] Thorp, 2008, Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice, Arterioscler. Thromb. Vasc. Biol. source
- Not checked yetcites [144] Yurdagul, 2017, Mechanisms and consequences of defective efferocytosis in atherosclerosis, Front. Cardiovasc Med. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Excessive and persistent accumulation of different senescent cells drives unique ageing and chronic disease development.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 4. Conclusions and Future Perspectives
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“p53-expressing senescent liver tumor cells recruit NK cells by inducing the chemokine CCL2 but not CCL3, CCL4 or CCL5, in senescent tumor cells without affecting the ligand expression of RAE-1 proteins in the tumor cells [153].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [153] Iannello, 2013, P53-dependent chemokine production by senescent tumor cells supports nkg2d-dependent tumor elimination by natural killer cells, J. Exp. Med. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Thus, apoptotic cells without CDKN2B impair macrophages efferocytosis and result in the development of advanced atherosclerotic plaques with large necrotic cores.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [149] Kojima, 2014, Cyclin-dependent kinase inhibitor 2b regulates efferocytosis and atherosclerosis, J. Clin. Investig. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“the adoptive constitution of engineered specific CAR-CD8+ T cells selectively targeting FAP notably alleviates cardiac fibrosis and reverses both systolic and diastolic cardiac function in angiotensin II and phenylephrine-treated mice [134].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [134] Aghajanian, 2019, Targeting cardiac fibrosis with engineered t cells, Nature source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“mice with defects in granule exocytosis accumulate senescent stellate cells and display stronger liver fibrosis in response to a fibrogenic agent [131].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [131] Sagiv, 2013, Granule exocytosis mediates immune surveillance of senescent cells, Oncogene source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Notably, ligands or antigens to activate the receptors NKG2D and DNAM-1 or ligands HLA-E for the inhibitory receptor NKG2A, have demonstrated expression in senescent cells.”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“NK cell activation by polyinosinic-polycytidylic acid [152] decreases the senescent cell number in the liver in vivo, leading to reduced liver fibrosis [20].”
§ Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases > 3. Immunosurveillance of Senescent Cells > 3.2. Immunotherapy to Eliminate Senescent Cells
What the sources say
- Not checked yetcites [152] Radaeva, 2006, Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in nkg2d-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners, Gastroenterology source
- Not checked yetcites [20] Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
Findings from animal models and preclinical studies of senescent cell clearance will translate to human ageing and chronic diseases.
“Mounting evidence indicates that immunotherapy targeting senescent cells combats ageing and chronic diseases and subsequently extends the healthy lifespan.”
The paper relies on this without support.
Targeting or clearing senescent cells can be done safely without eliminating beneficial functions of acute or transient senescence.
“Usually, sudden or acute senescence will exert beneficial functions such as anti-fibrosis [20] and wound healing [21].”
The paper relies on this without support.
Maintaining immune system function is sufficient to prevent or reduce pathological accumulation of senescent cells.
“A study investigating human ageing at the individual level by frequent sampling and prolonged deep molecular profiling indicates that immune pathways are one of the significant pathways that alter with age [38].”
The paper relies on this without support.
Selectivity and efficiency of cytotoxic T cells decline with age.
“However, the selectivity and efficiency of cytotoxic T cells decline with age.”
The paper relies on this without support.
Senescent cells are beneficial in the short term.
“Because senescent cells are also beneficial in the short term, the homeostasis of senescent cells is critical for healthy ageing.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“On the other hand, immune cell-mediated clearance of senescent cells is emerging as a promising strategy to fight multiple chronic diseases and aging.349”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [349]
In the citing paper
“the mechanisms underlying this immune escape closely mirror those utilized by tumor cells, offering valuable insights and a conceptual framework for the development of immune-based senotherapeutic strategies57,58.”
From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [58]
In the citing paper
“the mechanisms underlying this immune escape closely mirror those utilized by tumor cells, offering valuable insights and a conceptual framework for the development of immune-based senotherapeutic strategies57,58.”
From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [58]
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“Moreover, rapamycin, the US Food and Drug Administration-approved mTOR inhibitor, has been shown to extend the median and maximal lifespans of both male and female genetically heterogeneous mice [99].”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“However, excessive accumulation of senescent cells causally shortens the healthy lifespan [11] and drives organ ageing [12], age-related organ deterioration/disorders [13,14], tissue dysfunction and chronic diseases, including cardiovascular diseases (CVDs) [15,16], cancer [2], neurodegenerative diseases [17,18] and o…”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 8×
“Senescent cells generally demonstrate an enlarged and flattened cell morphology [27] and expanded nucleoli [28,29], enhanced senescence-associated beta-galactosidase (SA-β-gal) activity [30], telomere shortening, elevation of the cyclin-dependent kinase inhibitor p16 [11,31] or p21 [32], macromolecular damage and meta…”
BackgroundInfluentialCar t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207 · cited 1×
“Reinstructing cytotoxic T cells to identify specific antigens on cancer cells using either a modified T-cell receptor or a chimeric antigen receptor (CAR) has been successfully used for specific cancer therapies [156].”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“These senescent tumor cells recruit innate immune cells, such as macrophages, leading to the eradication of senescent tumor cells and subsequent tumor regression [145].”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“However, excessive accumulation of senescent cells causally shortens the healthy lifespan [11] and drives organ ageing [12], age-related organ deterioration/disorders [13,14], tissue dysfunction and chronic diseases, including cardiovascular diseases (CVDs) [15,16], cancer [2], neurodegenerative diseases [17,18] and o…”
BackgroundSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287 · cited 1×
“Although senescent cells can be induced to undergo apoptosis by senolytics [45,60,78,81,120], these apoptotic cells must be finally cleared by the immune system.”
BackgroundThe ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Flagged first, then by citations
Cited by
Sorted by citations
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
“(CAR-)T/NK for eliminating senescent cells On the other hand, immune cell-mediated clearance of senescent cells is emerging as a promising strategy to fight multiple chronic diseases and aging.(349) It was found that anti-uPAR-CAR-T cells were effective in removing senescent cells in vitro and precancerous and maligna…”
BackgroundImmunosenescence and inflammaging in the aging process: age-related diseases or longevity?
Santoro, A., Bientinesi, E., & Monti, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101422 · Cited by 603
Personal aging markers and ageotypes revealed by deep longitudinal profiling
Ahadi, S., Zhou, W., Schüssler-Fiorenza Rose, S. M., Sailani, M. R., Contrepois, K., Avina, M., Ashland, M., Brunet, A., & Snyder, M. (2020) · Nature Medicine · doi:10.1038/s41591-019-0719-5 · Cited by 408
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
Marín, I., Boix, O., García-Garijo, A., Sirois, I., Caballé, A., Zarzuela, E., Ruano, I., Attolini, C. S., Prats, N., Lopez-Dominguez, J. A., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0523 · Cited by 365
“The immune clearance of senescent cells is mediated by different populations of leukocytes, being better studied those belonging to the innate immune system (5, 16, 17).”
BackgroundSenescence mechanisms and targets in the heart
Chen, M. S., Lee, R. T., & Garbern, J. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab161 · Cited by 353
Metadata
- Authors
- Song, P., An, J., & Zou, M.-H.
- Affiliations
- Georgia State University (US)
- Corresponding author
- Song, Ping
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-03-10
- Volume
- 9
- Issue
- 3
- Pages
- 671
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7140645
- OpenAlex
- W3011483812
- Semantic Scholar
- 533bd613fedce791195cd41b29206c4ed982619d
- Cited by
- 198
- References
- 164
- Citations by year
- 2026: 22 · 2025: 37 · 2024: 40 · 2023: 23 · 2022: 38 · 2021: 24 · 2020: 12
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Foundation for the National Institutes of Health (AG047776, HL089920, HL110488, HL128014, HL132500, HL137371, HL140954, CA213022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- senescent cells, immune clearance, immunosenescence, senolytics, aging, chronic disease, tissue aging, immune cells, apoptosis, healthspan, small molecule drugs
- MeSH terms
- Aging, Chronic Disease, Humans, Immunotherapy, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review